Abstract

Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call